Biology:PPARGC1A

From HandWiki
Revision as of 12:17, 11 February 2024 by JStaso (talk | contribs) (update)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Short description: Protein


A representation of the 3D structure of the protein myoglobin showing turquoise α-helices.
Generic protein structure example

Peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α) is a protein that in humans is encoded by the PPARGC1A gene.[1] PPARGC1A is also known as human accelerated region 20 (HAR20). It may, therefore, have played a key role in differentiating humans from apes.[2]

PGC-1α is the master regulator of mitochondrial biogenesis.[3][4][5] PGC-1α is also the primary regulator of liver gluconeogenesis, inducing increased gene expression for gluconeogenesis.[6]

Function

PGC-1α is a gene that contains two promoters, and has 4 alternative splicings. PGC-1α is a transcriptional coactivator that regulates the genes involved in energy metabolism. It is the master regulator of mitochondrial biogenesis.[3][4][5] This protein interacts with the nuclear receptor PPAR-γ, which permits the interaction of this protein with multiple transcription factors. This protein can interact with, and regulate the activity of, cAMP response element-binding protein (CREB) and nuclear respiratory factors (NRFs) [citation needed]. PGC-1α provides a direct link between external physiological stimuli and the regulation of mitochondrial biogenesis, and is a major factor causing slow-twitch rather than fast-twitch muscle fiber types.[7]

Endurance exercise has been shown to activate the PGC-1α gene in human skeletal muscle.[8] Exercise-induced PGC-1α in skeletal muscle increases autophagy[9][10] and unfolded protein response.[11]

PGC-1α protein may also be involved in controlling blood pressure, regulating cellular cholesterol homeostasis, and the development of obesity.[12]

Regulation

PGC-1α is thought to be a master integrator of external signals. It is known to be activated by a host of factors, including:

  1. Reactive oxygen species and reactive nitrogen species, both formed endogenously in the cell as by-products of metabolism but upregulated during times of cellular stress.
  2. Fasting can also increase gluconeogenic gene expression, including hepatic PGC-1α.[13][14]
  3. It is strongly induced by cold exposure, linking this environmental stimulus to adaptive thermogenesis.[15]
  4. It is induced by endurance exercise[8] and recent research has shown that PGC-1α determines lactate metabolism, thus preventing high lactate levels in endurance athletes and making lactate as an energy source more efficient.[16]
  5. cAMP response element-binding (CREB) proteins, activated by an increase in cAMP following external cellular signals.
  6. Protein kinase B (Akt) is thought to downregulate PGC-1α, but upregulate its downstream effectors, NRF1 and NRF2. Akt itself is activated by PIP3, often upregulated by PI3K after G protein signals. The Akt family is also known to activate pro-survival signals as well as metabolic activation.
  7. SIRT1 binds and activates PGC-1α through deacetylation inducing gluconeogenesis without affecting mitochondrial biogenesis.[17]

PGC-1α has been shown to exert positive feedback circuits on some of its upstream regulators:

  1. PGC-1α increases Akt (PKB) and Phospho-Akt (Ser 473 and Thr 308) levels in muscle.[18]
  2. PGC-1α leads to calcineurin activation.[19]

Akt and calcineurin are both activators of NF-kappa-B (p65).[20][21] Through their activation, PGC-1α seems to activate NF-kappa-B. Increased activity of NF-kappa-B in muscle has recently been demonstrated following induction of PGC-1α.[22] The finding seems to be controversial. Other groups found that PGC-1s inhibit NF-kappa-B activity.[23] The effect was demonstrated for PGC-1 alpha and beta.

PGC-1α has also been shown to drive NAD biosynthesis to play a large role in renal protection in acute kidney injury.[24]

Clinical significance

Recently PPARGC1A has been implicated as a potential therapy for Parkinson's disease conferring protective effects on mitochondrial metabolism.[25]

Moreover, brain-specific isoforms of PGC-1alpha have recently been identified which are likely to play a role in other neurodegenerative disorders such as Huntington's disease and amyotrophic lateral sclerosis.[26][27]

Massage therapy appears to increase the amount of PGC-1α, which leads to the production of new mitochondria.[28][29][30]

PGC-1α and beta has furthermore been implicated in polarization to anti-inflammatory M2 macrophages by interaction with PPAR-γ[31] with upstream activation of STAT6.[32] An independent study confirmed the effect of PGC-1 on polarisation of macrophages towards M2 via STAT6/PPAR gamma and furthermore demonstrated that PGC-1 inhibits proinflammatory cytokine production.[33]

PGC-1α has been recently proposed to be responsible for β-aminoisobutyric acid secretion by exercising muscles.[34] The effect of β-aminoisobutyric acid in white fat includes the activation of thermogenic genes that prompt the browning of white adipose tissue and the consequent increase of background metabolism. Hence, the β-aminoisobutyric acid could act as a messenger molecule of PGC-1α and explain the effects of PGC-1α increase in other tissues such as white fat.

PGC-1α increases BNP expression by coactivating ERRα and / or AP1. Subsequently, BNP induces a chemokine cocktail in muscle fibers and activates macrophages in a local paracrine manner, which can then contribute to enhancing the repair and regeneration potential of trained muscles.

Most studies reporting effects of PGC-1α on physiological functions have used mouse models in which the PGC-1α gene is either knocked out or overexpressed from conception. However, some of the proposed effects of PGC-1α have been questioned by studies using inducible knockout technology to remove the PGC-1α gene only in adult mice. For example, two independent studies have shown that adult expression of PGC-1α is not required for improved mitochondrial function after exercise training.[35][36] This suggests that some of the reported effects of PGC-1α are likely to occur only in the developmental stage.

Interactions

PPARGC1A has been shown to interact with:

ERRα and PGC-1α are coactivators of both glucokinase (GK) and SIRT3, binding to an ERRE element in the GK and SIRT3 promoters.[citation needed]

See also

References

  1. ↑ "Human peroxisome proliferator activated receptor gamma coactivator 1 (PPARGC1) gene: cDNA sequence, genomic organization, chromosomal localization, and tissue expression". Genomics 62 (1): 98–102. Feb 2000. doi:10.1006/geno.1999.5977. PMID 10585775. 
  2. ↑ "An RNA gene expressed during cortical development evolved rapidly in humans". Nature 443 (7108): 167–72. September 2006. doi:10.1038/nature05113. PMID 16915236. Bibcode: 2006Natur.443..167P. https://dipot.ulb.ac.be/dspace/bitstream/2013/51805/3/pollard2006.pdf. 
  3. ↑ 3.0 3.1 "Mitochondrial biogenesis: pharmacological approaches". Curr. Pharm. Des. 20 (35): 5507–9. 2014. doi:10.2174/138161282035140911142118. PMID 24606795. "Mitochondrial biogenesis is therefore defined as the process via which cells increase their individual mitochondrial mass [3]. ... This work reviews different strategies to enhance mitochondrial bioenergetics in order to ameliorate the neurodegenerative process, with an emphasis on clinical trials reports that indicate their potential. Among them creatine, Coenzyme Q10 and mitochondrial targeted antioxidants/peptides are reported to have the most remarkable effects in clinical trials.". 
  4. ↑ 4.0 4.1 "Mitochondrial biogenesis in health and disease. Molecular and therapeutic approaches". Curr. Pharm. Des. 20 (35): 5619–5633. 2014. doi:10.2174/1381612820666140306095106. PMID 24606801. "Mitochondrial biogenesis (MB) is the essential mechanism by which cells control the number of mitochondria.". 
  5. ↑ 5.0 5.1 "Mitochondrial biogenesis and dynamics in the developing and diseased heart". Genes Dev. 29 (19): 1981–91. 2015. doi:10.1101/gad.269894.115. PMID 26443844. 
  6. ↑ "Biological and catalytic functions of sirtuin 6 as targets for small-molecule modulators". Journal of Biological Chemistry 295 (32): 11021–11041. 2020. doi:10.1074/jbc.REV120.011438. PMID 32518153. 
  7. ↑ "Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres". Nature 418 (6899): 797–801. 2002. doi:10.1038/nature00904. PMID 12181572. Bibcode: 2002Natur.418..797L. 
  8. ↑ 8.0 8.1 "Exercise induces transient transcriptional activation of the PGC-1alpha gene in human skeletal muscle". J. Physiol. 546 (Pt 3): 851–8. February 2003. doi:10.1113/jphysiol.2002.034850. PMID 12563009. 
  9. ↑ "Role of PGC-1α during acute exercise-induced autophagy and mitophagy in skeletal muscle". American Journal of Physiology 308 (9): C710-719. 2015. doi:10.1152/ajpcell.00380.2014. PMID 25673772. 
  10. ↑ "PGC-1α promotes exercise-induced autophagy in mouse skeletal muscle". Physiological Reports 4 (3): e12698. 2016. doi:10.14814/phy2.12698. PMID 26869683. 
  11. ↑ "The unfolded protein response mediates adaptation to exercise in skeletal muscle through a PGC-1α/ATF6α complex". Cell Metabolism 13 (2): 160–169. 2011. doi:10.1016/j.cmet.2011.01.003. PMID 21284983. 
  12. ↑ "Entrez Gene: PPARGC1A peroxisome proliferator-activated receptor gamma, coactivator 1 alpha". https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=10891. 
  13. ↑ Canettieri, G., Koo, S.-H., Berdeaux, R., Heredia, J., Hedrick, S., Zhang, X., & Montminy (2005). "Dual role of the coactivator TORC2 in modulating hepatic glucose output and insulin signaling". Cell Metabolism 2 (5): 331–338. doi:10.1016/j.cmet.2005.09.008. PMID 16271533. 
  14. ↑ Yoon, J. Cliff; Puigserver, Pere; Chen, Guoxun; Donovan, Jerry; Wu, Zhidan; Rhee, James; Adelmant, Guillaume; Stafford, John et al. (September 2001). "Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1" (in en). Nature 413 (6852): 131–138. doi:10.1038/35093050. ISSN 1476-4687. PMID 11557972. Bibcode: 2001Natur.413..131Y. https://www.nature.com/articles/35093050. 
  15. ↑ "PGC-1alpha: a key regulator of energy metabolism". Adv Physiol Educ 30 (4): 145–51. December 2006. doi:10.1152/advan.00052.2006. PMID 17108241. 
  16. ↑ "Skeletal muscle PGC-1α controls whole-body lactate homeostasis through estrogen-related receptor α-dependent activation of LDH B and repression of LDH A". Proc. Natl. Acad. Sci. U.S.A. 110 (21): 8738–43. May 2013. doi:10.1073/pnas.1212976110. PMID 23650363. PMC 3666691. Bibcode: 2013PNAS..110.8738S. http://edoc.unibas.ch/27589/4/Handschin_PNAS_2013.pdf. 
  17. ↑ "Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1". Nature 434 (7029): 113–8. March 2005. doi:10.1038/nature03354. PMID 15744310. Bibcode: 2005Natur.434..113R. 
  18. ↑ "Myopathy caused by mammalian target of rapamycin complex 1 (mTORC1) inactivation is not reversed by restoring mitochondrial function". Proc. Natl. Acad. Sci. U.S.A. 108 (51): 20808–13. December 2011. doi:10.1073/pnas.1111448109. PMID 22143799. Bibcode: 2011PNAS..10820808R. 
  19. ↑ "Remodeling of calcium handling in skeletal muscle through PGC-1α: impact on force, fatigability, and fiber type". Am. J. Physiol., Cell Physiol. 302 (1): C88–99. January 2012. doi:10.1152/ajpcell.00190.2011. PMID 21918181. http://edoc.unibas.ch/21241/1/6-PCG%201-Handschin-1.pdf. 
  20. ↑ "Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation". Trends Biochem. Sci. 30 (1): 43–52. January 2005. doi:10.1016/j.tibs.2004.11.009. PMID 15653325. https://orbi.uliege.be/bitstream/2268/1280/1/21.%20Review%20phosphorylation%20NF-kB%20TIBS.pdf. 
  21. ↑ "Multiple roles of the DSCR1 (Adapt78 or RCAN1) gene and its protein product calcipressin 1 (or RCAN1) in disease". Cell. Mol. Life Sci. 62 (21): 2477–86. November 2005. doi:10.1007/s00018-005-5085-4. PMID 16231093. 
  22. ↑ "Skeletal muscle PGC-1α is required for maintaining an acute LPS-induced TNFα response". PLOS ONE 7 (2): e32222. 2012. doi:10.1371/journal.pone.0032222. PMID 22384185. Bibcode: 2012PLoSO...732222O. 
  23. ↑ "Peroxisome proliferator-activated receptor gamma coactivator 1alpha or 1beta overexpression inhibits muscle protein degradation, induction of ubiquitin ligases, and disuse atrophy". J. Biol. Chem. 285 (25): 19460–71. June 2010. doi:10.1074/jbc.M110.113092. PMID 20404331. 
  24. ↑ "PGC1α drives NAD biosynthesis linking oxidative metabolism to renal protection". Nature 531 (7595): 528–32. 2016. doi:10.1038/nature17184. PMID 26982719. Bibcode: 2016Natur.531..528T. 
  25. ↑ "PGC-1{alpha}, A Potential Therapeutic Target for Early Intervention in Parkinson's Disease". Sci Transl Med 2 (52): 52ra73. October 2010. doi:10.1126/scitranslmed.3001059. PMID 20926834. 
  26. ↑ "A greatly extended PPARGC1A genomic locus encodes several new brain-specific isoforms and influences Huntington disease age of onset". Human Molecular Genetics 21 (15): 3461–73. 2012. doi:10.1093/hmg/dds177. PMID 22589246. 
  27. ↑ "PGC-1α is a male-specific disease modifier of human and experimental amyotrophic lateral sclerosis". Human Molecular Genetics 22 (17): 3477–84. 2013. doi:10.1093/hmg/ddt202. PMID 23669350. 
  28. ↑ "Massage therapy attenuates inflammatory signaling after exercise-induced muscle damage". Sci Transl Med 4 (119): 119ra13. February 2012. doi:10.1126/scitranslmed.3002882. PMID 22301554. 
  29. ↑ "Study works out kinks in understanding of massage". Los Angeles Times. 2012-02-01. http://www.latimes.com/health/la-he-massage-20120202,0,343517.story. 
  30. ↑ "Videos | The Buck Institute for Research on Aging". Buckinstitute.org. http://www.buckinstitute.org/videos. 
  31. ↑ "Low-intensity exercise enhances expression of markers of alternative activation in circulating leukocytes: roles of PPARγ and Th2 cytokines". Atherosclerosis 212 (2): 668–73. October 2010. doi:10.1016/j.atherosclerosis.2010.07.002. PMID 20723894. 
  32. ↑ "Peroxisome Proliferator-Activated Receptor-γ-Mediated Polarization of Macrophages in Leishmania Infection". PPAR Res 2012: 796235. 2012. doi:10.1155/2012/796235. PMID 22448168. 
  33. ↑ "Oxidative metabolism and PGC-1beta attenuate macrophage-mediated inflammation". Cell Metab. 4 (1): 13–24. July 2006. doi:10.1016/j.cmet.2006.05.011. PMID 16814729. 
  34. ↑ "β-Aminoisobutyric acid induces browning of white fat and hepatic β-oxidation and is inversely correlated with cardiometabolic risk factors". Cell Metabolism 19 (1): 96–108. 2014. doi:10.1016/j.cmet.2013.12.003. PMID 24411942. 
  35. ↑ "Adult expression of PGC-1α and -1β in skeletal muscle is not required for endurance exercise-induced enhancement of exercise capacity". Am J Physiol Endocrinol Metab 311 (6): E928–E938. October 2016. doi:10.1152/ajpendo.00209.2016. PMID 27780821. 
  36. ↑ "PGC-1α regulates mitochondrial properties beyond biogenesis with aging and exercise training". Am J Physiol Endocrinol Metab 317 (3): E513–E525. July 2019. doi:10.1152/ajpendo.00059.2019. PMID 31265325. 
  37. ↑ 37.0 37.1 "Activation of PPARgamma coactivator-1 through transcription factor docking". Science 286 (5443): 1368–71. November 1999. doi:10.1126/science.286.5443.1368. PMID 10558993. 
  38. ↑ "The estrogen-related receptor alpha (ERRalpha) functions in PPARgamma coactivator 1alpha (PGC-1alpha)-induced mitochondrial biogenesis". Proceedings of the National Academy of Sciences of the United States of America 101 (17): 6472–7. April 2004. doi:10.1073/pnas.0308686101. PMID 15087503. Bibcode: 2004PNAS..101.6472S. 
  39. ↑ "Peroxisome proliferator-activated receptor-γ coactivator 1α (PGC-1α) regulates triglyceride metabolism by activation of the nuclear receptor FXR". Genes Dev. 18 (2): 157–69. January 2004. doi:10.1101/gad.1138104. PMID 14729567. 
  40. ↑ "SCFCdc4 acts antagonistically to the PGC-1α transcriptional coactivator by targeting it for ubiquitin-mediated proteolysis". Genes Dev. 22 (2): 252–64. January 2008. doi:10.1101/gad.1624208. PMID 18198341. 
  41. ↑ 41.0 41.1 41.2 41.3 41.4 "Coordination of p300-mediated chromatin remodeling and TRAP/mediator function through coactivator PGC-1alpha". Mol. Cell 12 (5): 1137–49. November 2003. doi:10.1016/S1097-2765(03)00391-5. PMID 14636573. 
  42. ↑ "Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1". Cell 98 (1): 115–24. 1999. doi:10.1016/S0092-8674(00)80611-X. PMID 10412986. 
  43. ↑ "PGC-1 functions as a transcriptional coactivator for the retinoid X receptors". J. Biol. Chem. 277 (6): 3913–7. February 2002. doi:10.1074/jbc.M109409200. PMID 11714715. 
  44. ↑ "Requirement of helix 1 and the AF-2 domain of the thyroid hormone receptor for coactivation by PGC-1". J. Biol. Chem. 277 (11): 8898–905. March 2002. doi:10.1074/jbc.M110761200. PMID 11751919. 

Further reading

External links

This article incorporates text from the United States National Library of Medicine, which is in the public domain.



Retrieved from "https://handwiki.org/wiki/index.php?title=Biology:PPARGC1A&oldid=3555848"